Xinli Liu Selected Research

6- methoxy- 3- (3',4',5'- trimethoxybenzoyl)- 1H- indole

1/2013	An antimitotic and antivascular agent BPR0L075 overcomes multidrug resistance and induces mitotic catastrophe in paclitaxel-resistant ovarian cancer cells.
1/2012	Tubulin-destabilizing agent BPR0L075 induces vascular-disruption in human breast cancer mammary fat pad xenografts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xinli Liu Research Topics

Disease

31	Neoplasms (Cancer) 10/2022 - 07/2002
7	Breast Neoplasms (Breast Cancer) 10/2022 - 01/2012
5	Neoplasm Metastasis (Metastasis) 10/2022 - 11/2013
4	Melanoma (Melanoma, Malignant) 05/2021 - 04/2015
4	Uveitis 01/2021 - 01/2017
3	Ulcerative Colitis 04/2022 - 10/2021
3	Hypoxia (Hypoxemia) 01/2022 - 01/2021
3	Inflammation (Inflammations) 01/2022 - 01/2018
3	Infections 01/2021 - 05/2002
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2017 - 04/2015
3	Lung Neoplasms (Lung Cancer) 07/2017 - 04/2015
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2013
2	Colitis 01/2022 - 12/2018
2	Bites and Stings (Sting) 09/2021 - 07/2020
2	Osteoporosis 01/2021 - 07/2016
2	COVID-19 01/2021 - 07/2020
2	Drug-Related Side Effects and Adverse Reactions 01/2019 - 11/2010
2	Carcinogenesis 12/2018 - 09/2005
2	Alzheimer Disease (Alzheimer's Disease) 05/2006 - 09/2005
1	Gestational Diabetes (Gestational Diabetes Mellitus) 08/2022
1	Communicable Diseases (Infectious Diseases) 02/2022
1	Essential Hypertension 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Testicular Neoplasms (Testicular Cancer) 01/2022
1	Diarrhea 01/2022
1	Pre-Eclampsia (Preeclampsia) 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 10/2021
1	Multiple Myeloma 10/2021
1	Hyperopia (Hypermetropia) 05/2021
1	Refractive Errors (Refractive Error) 05/2021
1	Hemorrhage 04/2021
1	Hypercalcemia (Milk Alkali Syndrome) 01/2021
1	Central Nervous System Diseases (CNS Diseases) 01/2021
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2021
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2021

Drug/Important Bio-Agent (IBA)

7	Pharmaceutical PreparationsIBA 02/2022 - 11/2013
6	Proteins (Proteins, Gene)FDA Link 10/2022 - 06/2015
5	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2015
4	AntigensIBA 01/2022 - 04/2015
4	Liposomes (Liposome)IBA 01/2021 - 08/2011
3	Dextran SulfateIBA 04/2022 - 10/2021
3	LipopolysaccharidesIBA 01/2021 - 01/2017
3	EndotoxinsIBA 01/2018 - 01/2017
3	Hyaluronic Acid (Hyaluronan)IBA 06/2014 - 08/2011
2	ErbB Receptors (EGF Receptor)IBA 10/2022 - 10/2017
2	Epidermal Growth Factor (EGF)IBA 10/2022 - 01/2019
2	Small Interfering RNA (siRNA)IBA 01/2022 - 07/2016
2	Monoclonal AntibodiesIBA 10/2021 - 01/2021
2	Subunit VaccinesIBA 09/2021 - 07/2020
2	Messenger RNA (mRNA)IBA 11/2020 - 07/2017
2	VaccinesIBA 07/2020 - 05/2002
2	Polysaccharides (Glycans)IBA 12/2018 - 08/2011
2	CalreticulinIBA 02/2016 - 04/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2013 - 01/2013
2	6- methoxy- 3- (3',4',5'- trimethoxybenzoyl)- 1H- indoleIBA 01/2013 - 01/2012
2	Antimitotic AgentsIBA 01/2013 - 01/2012
2	TubulinIBA 01/2013 - 01/2012
2	NucleosidesIBA 05/2006 - 09/2005
2	DNA (Deoxyribonucleic Acid)IBA 05/2006 - 09/2005
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2022
1	tyrosine receptor (receptor, tyrosine)IBA 10/2022
1	Phosphotransferases (Kinase)IBA 10/2022
1	src-Family KinasesIBA 10/2022
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 08/2022
1	Long Noncoding RNAIBA 01/2022
1	OccludinIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	PlatinumIBA 01/2022
1	elotuzumabIBA 10/2021
1	daratumumabIBA 10/2021
1	Melanins (Melanin)IBA 05/2021
1	Mydriatics (Cycloplegics)IBA 05/2021
1	AcidsIBA 01/2021
1	GoldIBA 01/2021
1	puerarinIBA 01/2021
1	PolyphenolsIBA 01/2021
1	IsoflavonesIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2021
1	MineralsIBA 01/2021
1	CytokinesIBA 01/2021
1	Antinuclear AntibodiesIBA 01/2021
1	Zoledronic Acid (Zometa)FDA Link 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Amino Acids FDA Link 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	Diphosphonates (Bisphosphonates)IBA 01/2021
1	Clodronic Acid (Clodronate)IBA 01/2021

Therapy/Procedure

14	Therapeutics 02/2022 - 01/2011
4	Immunotherapy 01/2022 - 02/2016
4	Drug Therapy (Chemotherapy) 01/2022 - 11/2010
1	Chemoradiotherapy 01/2022
1	Cesarean Section (Caesarean Section) 01/2022
1	Operative Surgical Procedures 04/2021
1	Photothermal Therapy 01/2021
1	Intranasal Administration 01/2021